This human data firmly establishes that hypo-orexinemia accompanies insulin resistance and that pharmacological restoration of glycemic control upregulates orexin, suggesting a bidirectional, self-reinforcing loop between orexin signaling and metabolic health. The gene discussed is HCRT; the disease is Insulin resistance.